Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2003 1
2004 5
2005 5
2006 1
2007 3
2008 5
2009 2
2010 1
2011 3
2012 2
2013 5
2014 4
2015 5
2016 4
2018 4
2019 3
2020 12
2021 4
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Infection and vasculitis.
Belizna CC, Hamidou MA, Levesque H, Guillevin L, Shoenfeld Y. Belizna CC, et al. Rheumatology (Oxford). 2009 May;48(5):475-82. doi: 10.1093/rheumatology/kep026. Epub 2009 Mar 3. Rheumatology (Oxford). 2009. PMID: 19258377 Free PMC article. Review.
Prognosis of vasculitis associated myelodysplasia.
Belizna C, Subra JF, Henrion D, Ghali A, Renier G, Royer M, Corre YL, Martin L, Voswinkel J, Ifrah N. Belizna C, et al. Autoimmun Rev. 2013 Aug;12(10):943-6. doi: 10.1016/j.autrev.2013.01.005. Epub 2013 Mar 28. Autoimmun Rev. 2013. PMID: 23542504 Review.
Inclusion Body Myositis and Neoplasia: A Narrative Review.
Damian L, Login CC, Solomon C, Belizna C, Encica S, Urian L, Jurcut C, Stancu B, Vulturar R. Damian L, et al. Among authors: belizna c. Int J Mol Sci. 2022 Jul 1;23(13):7358. doi: 10.3390/ijms23137358. Int J Mol Sci. 2022. PMID: 35806366 Free PMC article. Review.
In utero exposure to Azathioprine in autoimmune disease. Where do we stand?
Belizna C, Meroni PL, Shoenfeld Y, Devreese K, Alijotas-Reig J, Esteve-Valverde E, Chighizola C, Pregnolato F, Cohen H, Fassot C, Mattera PM, Peretti P, Levy A, Bernard L, Saiet M, Lagarce L, Briet M, Rivière M, Pellier I, Gascoin G, Rakotonjanahary J, Borghi MO, Stojanovich L, Djokovic A, Stanisavljevic N, Bromley R, Elefant-Amoura E, Bahi Buisson N, Pindi Sala T, Kelchtermans H, Makatsariya A, Bidsatze V, Khizroeva J, Latino JO, Udry S, Henrion D, Loufrani L, Guihot AL, Muchardt C, Hasan M, Ungeheuer MN, Voswinkel J, Damian L, Pabinger I, Gebhart J, Lopez Pedrera R, Cohen Tervaert JW, Tincani A, Andreoli L. Belizna C, et al. Autoimmun Rev. 2020 Sep;19(9):102525. doi: 10.1016/j.autrev.2020.102525. Epub 2020 Mar 30. Autoimmun Rev. 2020. PMID: 32240856 Review.
Anti-Ku antibodies: Clinical, genetic and diagnostic insights.
Belizna C, Henrion D, Beucher A, Lavigne C, Ghaali A, Lévesque H. Belizna C, et al. Autoimmun Rev. 2010 Aug;9(10):691-4. doi: 10.1016/j.autrev.2010.05.020. Epub 2010 Jun 4. Autoimmun Rev. 2010. PMID: 20621654 Review.
Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities?
Belizna C, Stojanovich L, Cohen-Tervaert JW, Fassot C, Henrion D, Loufrani L, Nagy G, Muchardt C, Hasan M, Ungeheuer MN, Arnaud L, Alijotas-Reig J, Esteve-Valverde E, Nicoletti F, Saulnier P, Godon A, Reynier P, Chrétien JM, Damian L, Omarjee L, Mahé G, Pistorius MA, Meroni PL, Devreese K. Belizna C, et al. Autoimmun Rev. 2018 Aug;17(8):739-745. doi: 10.1016/j.autrev.2018.01.027. Epub 2018 Jun 6. Autoimmun Rev. 2018. PMID: 29885541 Free article. Review.
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.
Alijotas-Reig J, Esteve-Valverde E, Belizna C, Selva-O'Callaghan A, Pardos-Gea J, Quintana A, Mekinian A, Anunciacion-Llunell A, Miró-Mur F. Alijotas-Reig J, et al. Among authors: belizna c. Autoimmun Rev. 2020 Jul;19(7):102569. doi: 10.1016/j.autrev.2020.102569. Epub 2020 May 3. Autoimmun Rev. 2020. PMID: 32376394 Free PMC article. Review.
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.
Belizna C, Pregnolato F, Abad S, Alijotas-Reig J, Amital H, Amoura Z, Andreoli L, Andres E, Aouba A, Apras Bilgen S, Arnaud L, Bienvenu B, Bitsadze V, Blanco P, Blank M, Borghi MO, Caligaro A, Candrea E, Canti V, Chiche L, Chretien JM, Cohen Tervaert JW, Damian L, Delross T, Dernis E, Devreese K, Djokovic A, Esteve-Valverde E, Favaro M, Fassot C, Ferrer-Oliveras R, Godon A, Hamidou M, Hasan M, Henrion D, Imbert B, Jeandel PY, Jeannin P, Jego P, Jourde-Chiche N, Khizroeva J, Lambotte O, Landron C, Latino JO, Lazaro E, de Leeuw K, Le Gallou T, Kiliç L, Limper M, Loufrani L, Lubin R, Magy-Bertrand N, Mahe G, Makatsariya A, Martin T, Muchardt C, Nagy G, Omarjee L, Van Paasen P, Pernod G, Perrinet F, Pïres Rosa G, Pistorius MA, Ruffatti A, Said F, Saulnier P, Sene D, Sentilhes L, Shovman O, Sibilia J, Sinescu C, Stanisavljevic N, Stojanovich L, Tam LS, Tincani A, Tollis F, Udry S, Ungeheuer MN, Versini M, Cervera R, Meroni PL. Belizna C, et al. Autoimmun Rev. 2018 Dec;17(12):1153-1168. doi: 10.1016/j.autrev.2018.05.012. Epub 2018 Oct 12. Autoimmun Rev. 2018. PMID: 30316994 Review.
73 results